Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 10/20 | 0.54 |
| ▸ | REN | P00797 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | PEPD | P12955 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | HRH1 | P35367 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Acetylproline SCHEMBL428476 | 1.00 | ACE (0.54) | ACERENLMNAHSD17B10CYP2C19 | |
| N-Acetylproline SCHEMBL428477 | 1.00 | ACE (0.54) | ACERENLMNAHSD17B10CYP2C19 | |
| N-Acetylproline SCHEMBL6469164 | 0.98 | ACE (0.53) | ACERENLMNAHSD17B10CYP2C19 | |
| N-Acetylproline SCHEMBL1375025 | 0.98 | ACE (0.53) | ACERENLMNAHSD17B10CYP2C19 | |
| N-Acetylproline SCHEMBL1375029 | 0.98 | ACE (0.53) | ACERENLMNAHSD17B10CYP2C19 | |
| SCHEMBL5860164 | 0.94 | ACE (0.49) | ACERENLMNAHSD17B10CYP2C19 | |
| SCHEMBL7054783 | 0.94 | ACE (0.49) | ACERENLMNAHSD17B10CYP2C19 | |
| SCHEMBL1840265 | 0.94 | ACE (0.49) | ACERENLMNAHSD17B10CYP2C19 | |
| SCHEMBL19566169 | 0.92 | ACE (0.56) | ACERENLMNAHSD17B10CYP2C19 | |
| SCHEMBL22423638 | 0.92 | ACE (0.56) | ACERENLMNAHSD17B10CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658228-A1 | ECO-BIOLOGICAL COSMETIC COMPOSITION SUITABLE FOR REDUCING THE SIGNS OF CUTANEOUS AGEING | Thorel, Jean-Noël (FR) | 2025-12-10 | — | — | EP | claimed |
| CN-120064663-A | Metabolic marker for distinguishing hypertrophic cardiomyopathy and left ventricular hypertrophy and application | 中国医学科学院阜外医院 | 2025-05-30 | — | — | CN | claimed |
| EP-3615069-B1 | N-ACETYLATED AND NON-ACETYLATED DIPEPTIDES CONTAINING ARGININE TO REDUCE THE VISCOSITY OF VISCOUS COMPOSITIONS OF THERAPEUTIC POLYPEPTIDES | AMGEN INC (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119523841-A | Transdermal composition with whitening and freckle removing effects and preparation method thereof | 广州御清堂化妆品有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119517408-A | Method for establishing death prediction model of new-onset type 2 diabetes and application | 中南大学湘雅二医院 | 2025-02-25 | — | — | CN | claimed |
| US-12103979-B2 | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides | AMGEN INC. (US) | 2024-10-01 | — | — | US | claimed |
| US-12076432-B2 | Method of repairing oxidatively treated hair | CONOPCO, INC. (US) | 2024-09-03 | — | — | US | claimed |
| CN-118542948-A | Nanometer medicinal preparation for treating sepsis, and its preparation method and application | 四川大学 | 2024-08-27 | — | — | CN | claimed |
| WO-2024161085-A1 | ECO-BIOLOGICAL COSMETIC COMPOSITION SUITABLE FOR REDUCING THE SIGNS OF CUTANEOUS AGEING | NAOS INSTITUTE OF LIFE SCIENCE (FR) | 2024-08-08 | — | — | WO | claimed |
| CN-117721474-A | Cleaning agent for chip after chemical mechanical polishing, preparation method and application thereof | 江苏奥首材料科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| EP-0508133-B1 | Method of preparation of L-Carnitine from D,L-Carnitine nitrile salts | DEGUSSA (DE) | 1995-02-15 | — | — | EP | claimed |
| WO-1995001990-A1 | HEMOREGULATORY PENTA- OR HEXAPEPTIDES | NYCOMED PHARMA A.S (NO) | 1995-01-19 | — | — | WO | claimed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0416282-B1 | Microbiologically produced N-Acyl-L-proline-acylase, process for its production and its use | DEGUSSA (DE) | 1994-09-14 | — | — | EP | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| US-5219741-A | Reacting in the presence of microbiologically produced N-acyl-L-proline acylase | DEGUSSA AG (DE) | 1993-06-15 | — | — | US | claimed |
| US-5166426-A | PROCESS FOR PRODUCING L-CARNITINE FROM D,L-CARNITINE NITRILE SALTS | DEGUSSA AG (DE) | 1992-11-24 | — | — | US | claimed |
| EP-0508133-A2 | Method of preparation of L-Carnitine from D,L-Carnitine nitrile salts | DEGUSSA AG (DE) | 1992-10-14 | — | — | EP | claimed |
| US-5120652-A | Synthesis of proline from acyl derivatives; thermostable | DEGUSSA AG (DE) | 1992-06-09 | — | — | US | claimed |
| US-4085207-A | AND AT LEAST ONE OF N-ACYL-L-TRYPTOPHANS AND N-ACYL-L-PROLINES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JA) | 1978-04-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12103979-B2 | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides | ARGLU1, PNISR, DNPEP | ACE 1472/4885REN 1633/4885LMNA 2659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.